This site contains promotional information intended only for healthcare professionals resident in the United Kingdom

Visit Pfizer Medical site

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
Linked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
EN - EnglishSelect a languageLanguagesEN - EnglishFR - Françias

Menu

Close

Sign InLog Out
  • EN
Single LinkDropdownLabelLinkLinkLinkLinkLinked DropdownLabelLinkLinkLinkLinkMega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
Linked Mega MenuHeading

Example of description text sitting alongside header

LabelLinkLinkLinkLinkLabelLinkLinkLinkLinkLabelLinkLinkLinkLink
EN - EnglishSelect a languageLanguagesEN - EnglishFR - Françias
Search

Menu

Close

Sign In or RegisterLog Out
Pfizer MedicinesTherapy AreasExplore ContentEventsVideosMaterialsFeatured ArticlesLet’s ConnectSupplyAlliance HealthcareOff-contract claims

Adverse event reporting can be found at the bottom of the page

CommitmentHeritageInitiativesInnovationPortfolio

Menu

Close

Information on adverse event reporting can be found at the bottom of this page.

​​​​​​​Committed To Those Affected By Cancer

Pfizer Oncology has a longstanding commitment to helping those affected by cancer. By placing patients and collaboration at the centre of everything we do, we believe we can have a meaningful impact on the lives of cancer patients - both now and in the future.

Our Efforts Against Cancer 

Every day, around 1,000 people are diagnosed with cancer in the UK.But, thanks to innovative treatments and significant advances in the understanding of the disease, more people than ever are surviving cancer.2

At Pfizer Oncology, we have a portfolio of more than 20 approved innovative cancer medicines and biosimilars across over 30 indications, including melanoma, breast, genitourinary, colorectal, blood and lung cancers.3 Find out more.

We've made meaningful progress - but our work is far from finished. Currently, there are over 200 Pfizer-sponsored Oncology clinical trials ongoing globally, with studies spanning more than 20 different tumour types and subtypes.Learn more.

Building Partnerships

At Pfizer UK, we are proud of our long history of successfully partnering with organisations that share our purpose to deliver the right treatment for each patient at the right time. We also partner with scientists, academics and clinicians, to share knowledge, skills and expertise, with the aim to improve the health and lives of people in the UK and around the world.

Over the past 70 years, we have continued to invest in the UK and are committed to working with the National Health Service (NHS) and other healthcare organisations across the industry, developing solutions to improve the delivery of care and patient outcomes. The NHS has access to over 150 Pfizer medicines and vaccines that are delivered to pharmacies, surgeries, and hospitals across the UK every day.5

We also partner with relevant policy-makers and other stakeholders, driven by our purpose to deliver breakthroughs that could change patients' lives.

​​​​​​​Empowering Patients

Patients are now -  more than ever - equipped, informed and empowered to define healthcare in their own terms. At Pfizer, we recognise the importance of harnessing the power of patient experiences to understand what healthcare means to the individual. Through our commitment to working together, we aim to personalise patient care and deliver better healthcare for the people that matter most - patients.

Patient centricity within Pfizer Oncology is a longstanding tradition. Over the years, our team has cultivated relationships with many patient advocates across the world - with the common goals of ensuring health equity and literacy for all, and supporting patient engagement in clinical trials.

In 2019, to expand these efforts and further embed patient insights and experiences into all activities, Pfizer Oncology launched an initiative to create a Patient Centric Ecosystem (POPCE). The initiative ensures a continued focus on patient centricity by engaging and collaborating with advocacy leaders on priority activities identified by advocates. Today, this ecosystem is continuing to yield actionable insights, providing opportunities for information-sharing and partnership across the cancer community.4

Committed To The Future

At Pfizer, we are relentless in our pursuit of medicines and vaccines that could benefit patients around the world. By 2025, we hope that our medicines will help to treat 225 million people.3

In addition to our medicines, we are also supporting patients through innovative technologies, such as the free ByYourSideTM app, a digital support programme designed specifically to help people living with cancer, as well as their friends and family members. Download ByYourSideTM from the Apple App Store or get it on Google Play.6

In the UK, we are also investing in the future by supporting the scientists of tomorrow through the UK's National Apprenticeship Programme, our undergraduate placement scheme and various STEM (Science, Technology, Engineering and Mathematics) and SIP (Science Industry Partnership) activities.5 Find out more

Related Content
Our Oncology Portfolio

Our portfolio of treatments stretches across multiple indications, including breast, genitourinary, blood and lung cancers.

Find out moreLoading
Innovation in Oncology

We believe nothing is more urgent, or more personal, than our goal to develop the next generation of potential cancer therapies.

Find out moreLoading
Our Oncology Heritage

For over two decades, we have worked tirelessly in our pursuit to develop innovative and accessible treatments for those living with cancer. 

Find out moreLoading
Initiatives in Oncology

In addition to manufacturing medicines, we're engaged in a number of initiatives that we hope will improve the lives of those impacted by cancer.

Find out moreLoading

References:

1. International Agency for Research on Cancer (IARC). United Kingdom Factsheet. Available at: https://gco.iarc.fr/today/data/factsheets/populations/826-united-kingdom-fact-sheets.pdf. Last accessed September 2023.
2. Maddams J, Utley M, Møller H. Projections of cancer prevalence in the United Kingdom, 2010-2040. Br J Cancer 2012; 107 (7):1195-202. 
3. Pfizer data on file. 
4. Pfizer Oncology Patient Centricity Ecosystem: From Launch to Impact. Available at: https://cdn.pfizer.com/pfizercom/Pfizer_APR_WhitePaper_080921.pdf. Last accessed September 2023.
5. Pfizer.co.uk. Pfizer in the UK. Available at: https://www.pfizer.co.uk/our-science/pfizer-uk. Last accessed September 2023.
6. ByYourSide. ByYourSide App. Available at: https://www.byyourside.co.uk/byyourside-app. Last accessed September 2023. 

PP-UNP-GBR-6628. October 2023

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard or search 

for MHRA Yellow Card in Google Play or Apple App Store

 

Adverse events should also be reported to Pfizer Medical Information on 01304 616161

PfizerPro Account

To access further materials, resources and receive communication about medicines and vaccines promoted by Pfizer.

Sign In or RegisterAccountSign Out

This site is intended only for healthcare professionals resident in the United Kingdom. If you are a member of the public wishing to access information on a specific medicine, please visit www.medicines.org.uk/emc

 

This website is brought to you by Pfizer Limited, a company registered in England 

and Wales under No. 526209 with its registered office at Ramsgate Road, Sandwich, Kent, CT13 9NJ

 

Copyright © 2023 Pfizer Limited. All rights reserved.

 

VAT registration number GB201048427

PP-UNP-GBR-7284. November 2023
For UK Healthcare Professionals*

These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.

I confirm that I am a healthcare professional* resident in the United Kingdom.

If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.

*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.

PP-PFE-GBR-3863. November 2021

YesNo
You are now leaving PfizerPro​​​​​

​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned or controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site.​​​​​​​​​​​​​​

​​​​​​​PP-PFE-GBR-3858. November 2021​​​​​​​
​​​​​​​
You are now leaving PfizerPro
​​​​​​​
​​​​​​​You are now leaving www.pfizerpro.co.uk. Links to external websites are provided as a resource to the viewer. This website is neither owned nor controlled by Pfizer Ltd. 

Pfizer accepts no responsibility for the content or services of the linked site other than the information or other materials relating to ​​​​​Pfizer medicines or 
business which it has provided or reviewed.

PP-PFE-GBR-3859. November 2021
​​​​​​​